Related Experiment Videos
Malignant lymphoma of the testis
M M Fickers1, J Koudstaal, F P van de Weijer
1Department of Internal Medicine, Wever Hospital, Heerlen, The Netherlands.
The Netherlands Journal of Medicine
|August 1, 1991
Summary
Primary non-Hodgkin's lymphoma of the testis has a poor prognosis. Aggressive chemotherapy following surgery is recommended, with tailored approaches for elderly patients and specific CNS or advanced stage interventions.
Area of Science:
- Oncology
- Hematology
- Urologic Oncology
Background:
- Primary non-Hodgkin's lymphoma of the testis is a rare malignancy.
- Intermediate-grade lymphomas require specific treatment strategies.
Observation:
- Five patients with intermediate-grade primary testicular non-Hodgkin's lymphoma were analyzed.
- Central nervous system (CNS) infiltration was observed in 3 out of 5 patients.
- Survival rates were poor, with a median survival of 7.5 months.
Findings:
- Aggressive chemotherapy (≥3 cytostatics) post-orchidectomy and staging is recommended.
- Systemic therapy needs to be effective for younger patients and adapted for elderly patients (>70 years).
- Prophylactic scrotal ultrasonography is essential; prophylactic testicular radiation is not advised.
Implications:
- Early and aggressive multimodal treatment can potentially improve outcomes for testicular lymphoma.
- Tailored chemotherapy regimens and CNS-directed therapies are crucial for managing this disease.
- Close monitoring with scrotal ultrasonography is vital for early detection of recurrence or contralateral involvement.